Concord Healthcare Completes HK$68 Million Convertible Bond Issue to CSPC Pharma Unit

MT Newswires Live05-14

Concord Healthcare (HKG:2453) completed the issuance of HK$68 million convertible bonds to a unit of CSPC Pharmaceutical (HKG:1093), according to a Wednesday Hong Kong bourse filing.

Shares of the medical services firm were down over 2% in Thursday morning trade.

The company issued the 2% convertible bonds due April 2027 to Dragon Merit after all conditions under the placing and subscription agreement were fulfilled.

The bonds are convertible into as much as 40 million Hong Kong-listed shares at an initial conversion price of HK$1.70 per share.

Concord Healthcare previously said net proceeds of about HK$63.1 million would mainly be used to repay loans and supplement working capital.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment